Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 5 of 5 clinical reviews.
A clinical deep dive into Peter Attia's publicly confirmed use of testosterone replacement therapy and rapamycin, with peer-reviewed context on mechanisms, dosing, and risk profiles.
Read clinical reviewHow Peter Attia's confirmed testosterone replacement and rapamycin protocols compare to other celebrities who have publicly discussed longevity pharmacology, with clinical context from the HealthRX Medical Team.
Read clinical reviewA clinical breakdown of Peter Attia's publicly documented testosterone replacement therapy and rapamycin use, mapped against his physical changes and public statements over the past decade.
Read clinical reviewPeter Attia has publicly confirmed using testosterone replacement therapy and weekly rapamycin. The HealthRX Medical Team examines what the clinical literature says about long-term use, discontinuation risks, and maintenance protocols for both.
Read clinical reviewPeter Attia has openly discussed side effects from testosterone replacement therapy and rapamycin. The HealthRX Medical Team maps his public statements to FDA labels and peer-reviewed trial data.
Read clinical review